Stay updated on Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page gains new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note indicating recruitment is closed; the Intervention/Treatment header is standardized, and the revision note updates from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-10T19:45:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Study locations were updated to reflect a new Blacksburg, VA site (ZIP 24060) and the removal of the previous ZIP 24014. This change updates the geographic availability of trial sites.
    Difference
    0.2%
    Check dated 2026-06-03T09:37:32.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    - The page revision changed from v3.5.3 to v3.5.4, indicating a newer version of the study record.
    Difference
    0.0%
    Check dated 2026-05-20T06:45:41.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    - New timestamps were added to the Study Record Dates to reflect the most recent maintenance events (QC submission and posting). These entries update the record's activity timeline.
    Difference
    0.2%
    Check dated 2026-05-06T02:18:30.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study's Locations section was updated to reflect 39 participating sites, replacing the previous larger roster and changing the geographic mix of sites.
    Difference
    3%
    Check dated 2026-04-28T21:42:51.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Updated the displayed revision/version from **v3.5.0** to **v3.5.2**.
    Difference
    0.0%
    Check dated 2026-04-21T15:58:26.000Z thumbnail image

Stay in the know with updates to Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page.